Production (Stage)
Processa Pharmaceuticals, Inc.
PCSA
$0.3006
$0.01033.55%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 143.19% | -58.80% | -48.10% | -37.55% | 89.55% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 26.16% | -64.95% | 2.09% | 122.35% | -7.42% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 100.57% | -61.27% | -35.30% | -23.70% | 74.00% |
|
|||||
Total Current Assets | 100.57% | -61.27% | -35.30% | -23.70% | 74.00% |
Net Property, Plant & Equipment | -30.65% | -23.15% | -16.17% | -15.41% | -6.53% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -21.94% | 23,172.73% | 0.00% | 0.00% | 0.00% |
Total Assets | 48.94% | -34.66% | -34.98% | -23.57% | 71.86% |
|
|||||
Total Accounts Payable | -37.27% | 23.77% | -25.33% | 109.29% | 46.15% |
Total Accrued Expenses | 17.63% | 40.19% | -18.32% | 8.55% | 218.25% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -31.92% | -22.91% | 1.61% | 3.90% | 7.30% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -16.29% | 25.71% | -21.43% | 53.53% | 38.34% |
|
|||||
Total Current Liabilities | -16.29% | 25.71% | -21.43% | 53.53% | 38.34% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -77.27% | -91.41% | -49.51% | -24.22% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -16.31% | 25.52% | -22.56% | 48.61% | 33.09% |
|
|||||
Common Stock & APIC | 5.23% | 0.80% | 1.24% | 0.17% | 8.21% |
Retained Earnings | -3.25% | -3.23% | -4.17% | -3.85% | -3.62% |
Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Common Equity | 107.91% | -54.41% | -38.23% | -32.19% | 78.05% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 107.91% | -54.41% | -38.23% | -32.19% | 78.05% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 107.91% | -54.41% | -38.23% | -32.19% | 78.05% |
|